RUA Life Sciences plc (AIM:RUA)
London · Delayed Price · Currency is GBP · Price in GBX 19.85
+0.35 (1.79%)
Jun 17, 2026, 10:43 AM GMT
RUA Life Sciences Market Cap
RUA Life Sciences has a market cap or net worth of 12.1 million as of June 17, 2026. Its market cap has increased by 65.96% in one year.
Market Cap
12.10M
Enterprise Value
9.69M
Revenue
4.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.85
Market Cap Chart
Since February 26, 1997, RUA Life Sciences's market cap has decreased from 23.82M to 12.10M, a decrease of -49.20%. That is a compound annual growth rate of -2.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 12.10M | 39.29% |
| Dec 31, 2025 | 8.69M | 27.27% |
| Dec 31, 2024 | 6.83M | 11.68% |
| Dec 29, 2023 | 6.11M | -43.19% |
| Dec 30, 2022 | 10.76M | -35.33% |
| Dec 31, 2021 | 16.64M | -50.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 206.03B |
| GSK plc | 77.84B |
| Haleon | 29.53B |
| Smith & Nephew | 9.60B |
| Aptamer Group | 17.28M |
| Palatin Technologies | 16.83M |
| Cambridge Cognition Holdings | 16.76M |
| Fusion Antibodies | 15.00M |